SPRINGFIELD, Ill. (WTVO) — Twelve state’s attorney generals, including Illinois’ Kwame Raoul, are suing the FDA to make pills often used in abortions more accessible.
The lawsuit accuses the FDA of singling out “Mifepristone” and imposing burdensome limitations on distribution.
Heath care providers and pharmacies are required to follow a certification process with the drug, and patients are required to sign a form that says they are expressly taking it to end a pregnancy, even if they are being treated for a miscarriage.
Anti-abortion groups filed a lawsuit in November in an attempt to get the FDA to rescind its approval of the drug. The FDA first approved the pill in 2000, which falls under the agency’s “REMS” restriction.
Medication that the FDA views as having serious safety concerns are put in that category.
The American College of Obstetricians and Gynecologists said that Mifepristone is “safe and effective.”
“Illinois Right to Life,” an anti-abortion group, does not support the use of it.
“Illinois is interested in expanding the abortion industry as much as they possibly can,” said Kate Zander, executive director of Illinois Right to Life. “That’s why we’ve seen so many abortion clinics open in the state over the last few years, because they are looking to make up for where they are losing in their bottom line in other states that abortion is now illegal.”
The lawsuit comes as a federal judge in Texas is set to decide a case brought by an anti-abortion group. They want the FDA to reverse that decision and take it off the market entirely.
More than half of abortions in the U.S. happen with that drug.